In our study, olaparib upregulated RNA and protein expression of the granulocytic and monocytic transcription factors PU.1 and CEBPA, both proteins reported to be frequently downregulated in myeloid malignancies [33,34,35]. Here, CEBPA is linked to myeloid neoplasm.